CN Stock MarketDetailed Quotes
300439 Medicalsystem Biotechnology
- 10.83
- +0.10+0.93%
Noon Break Oct 14 11:30 CST
4.16BMarket Cap15.97P/E (TTM)
10.90High10.50Low37.02KlotVolume10.86Open10.73Pre Close39.70MTurnover1.27%Turnover Ratio16.21P/E (Static)383.95MShares13.2452wk High1.46P/B3.16BFloat Cap7.1552wk Low12.88Limit Up291.73MShs Float77.92Historical High8.58Limit Down3.73%Amplitude7.15Historical Low0.13Dividend TTM10.72Avg Price18.85KlotAsk1.24%Div YieldTTM100Lot Size16.38KlotBid
Medicalsystem Biotechnology Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -22.27%713.16M | 4.63%809.34M | 18.91%958.88M | 32.49%929.32M | 47.93%917.45M | 22.97%773.54M | 21.03%806.41M | 5.61%701.44M | 3.27%620.17M | -5.17%629.03M |
| Transactional financial assets | --188.21M | -12.30%70.2M | -92.52%6M | ---- | ---- | --80.05M | -20.39%80.17M | --50.78M | -64.20%50.36M | ---- |
| Notes receivable and accounts receivable | -15.48%581.67M | -21.22%577.48M | -30.45%567.72M | -27.03%681.62M | -28.47%688.23M | -14.92%732.99M | 0.67%816.25M | -5.31%934.11M | 4.63%962.18M | -12.00%861.5M |
| -Notes receivable | ---- | --3.8M | ---- | 180.07%1.06M | --712.75K | ---- | --380K | --380K | ---- | ---- |
| -Accounts receivable | -15.40%581.67M | -21.73%573.68M | -30.42%567.72M | -27.11%680.56M | -28.55%687.52M | -14.92%732.99M | 0.62%815.87M | -5.35%933.73M | 4.72%962.18M | -11.93%861.5M |
| Other receivables (including interest and dividends) | -70.14%19.68M | -65.24%28.87M | -52.01%36.32M | -36.50%57.07M | -35.15%65.9M | -21.57%83.06M | 64.92%75.69M | 78.85%89.86M | 112.65%101.63M | 97.05%105.9M |
| -Dividend receivable | ---- | ---- | ---- | -18.27%8.77M | -45.81%5.82M | -19.42%8.72M | 84.08%10.84M | 119.50%10.74M | 82.39%10.74M | 8.82%10.82M |
| -Other receivable | -67.25%19.68M | ---- | -43.99%36.32M | ---- | -33.90%60.08M | ---- | 62.10%64.85M | ---- | 116.91%90.88M | ---- |
| Advance payment | -50.68%32.91M | -28.97%43.22M | -31.24%44.41M | 28.96%82.89M | -11.35%66.71M | -26.48%60.85M | 42.57%64.59M | 17.19%64.28M | 16.14%75.26M | 57.10%82.76M |
| Inventories | 19.50%248.85M | 11.42%234.76M | 18.79%259.01M | -3.70%221.86M | -9.50%208.24M | -15.89%210.7M | 3.14%218.03M | 2.94%230.37M | 5.33%230.11M | -0.10%250.5M |
| Receivable financing | ---- | --700K | 1,876.64%2.2M | 1,247.71%1.5M | ---- | ---- | -99.35%111.3K | -99.07%111.3K | -15.86%7.45M | 71.76%19.91M |
| Other current assets | 1,026.20%27.32M | 114.20%26.6M | 139.08%24.62M | 909.04%20.24M | -21.93%2.43M | -9.87%12.42M | -22.05%10.3M | -83.95%2.01M | -86.36%3.11M | -42.48%13.78M |
| Total current assets | -7.04%1.81B | -8.31%1.79B | -8.32%1.9B | -3.78%1.99B | -4.94%1.95B | -0.50%1.95B | 3.07%2.07B | 3.44%2.07B | -2.04%2.05B | -3.52%1.96B |
| Non Current assets | ||||||||||
| Other equity investment | -52.20%5M | -8.45%5M | -8.45%5M | 91.55%10.46M | 91.55%10.46M | 0.00%5.46M | 0.00%5.46M | 0.00%5.46M | 0.00%5.46M | 0.00%5.46M |
| Investment real estate | ---- | ---- | ---- | -2.72%99.71M | -2.70%100.44M | -2.45%101.07M | 2.31%101.96M | 2.14%102.49M | 13.35%103.23M | 54.89%103.61M |
| Long-term equity investment | 1.55%167.27M | 1.33%162.24M | -0.82%155.94M | -5.77%170.56M | -6.99%164.72M | -10.83%160.1M | -12.11%157.24M | -5.83%181M | -26.08%177.1M | -28.79%179.56M |
| Fixed assets | 25.40%990.2M | ---- | 18.19%981.58M | ---- | -3.25%789.61M | ---- | -3.46%830.52M | ---- | -5.32%816.17M | ---- |
| Constru in process | -8.52%249.52M | ---- | -15.44%160.5M | ---- | 62.82%272.76M | ---- | 34.50%189.8M | ---- | 20.89%167.52M | ---- |
| Intangible assets | 8.67%123.69M | 6.14%125.47M | 6.37%127.85M | -20.88%112.18M | -19.45%113.82M | -17.60%118.21M | -18.99%120.19M | -7.04%141.79M | -8.05%141.31M | -7.24%143.47M |
| Long deferred expense | 120.50%31.07M | 82.93%28.79M | 84.66%34.34M | 4.53%28.02M | -53.26%14.09M | -49.84%15.74M | -47.22%18.6M | -33.51%26.81M | -36.65%30.15M | -46.42%31.38M |
| Deferred tax assets | 27.61%42.57M | 26.09%36.39M | 39.05%35.53M | -25.88%29.8M | -13.24%33.36M | -27.58%28.86M | -37.84%25.55M | 0.06%40.2M | 1.03%38.45M | 10.49%39.85M |
| Usufruct assets | -17.93%30.34M | -24.32%31.94M | -19.40%36.22M | -7.19%32.28M | -0.32%36.98M | -4.92%42.2M | -4.35%44.94M | 60.91%34.79M | 62.63%37.09M | 84.95%44.39M |
| Other non current assets | 65.67%59.34M | 315.97%56.07M | 197.07%53.05M | -51.35%12.28M | -30.74%35.82M | -61.65%13.48M | -31.71%17.86M | -23.27%25.25M | 28.71%51.72M | -3.95%35.15M |
| Total non current assets | 8.08%1.7B | 8.53%1.65B | 5.15%1.59B | 0.23%1.57B | 0.25%1.57B | -2.90%1.52B | -4.49%1.51B | -2.64%1.56B | -5.11%1.57B | -7.70%1.56B |
| Total assets | -0.29%3.51B | -0.95%3.44B | -2.64%3.49B | -2.06%3.56B | -2.69%3.52B | -1.56%3.47B | -0.26%3.58B | 0.74%3.64B | -3.40%3.62B | -5.42%3.53B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -75.00%30.02M | -79.31%30.02M | -77.01%50.05M | -64.70%120.1M | -64.70%120.08M | -57.34%145.13M | -35.99%217.76M | -21.54%340.21M | -34.30%340.21M | -43.97%340.17M |
| Notes payable and accounts payable | -9.32%340.43M | -7.88%319.81M | -10.90%333.46M | -4.05%341.83M | -7.81%375.4M | 7.79%347.16M | 12.95%374.26M | -1.13%356.26M | 17.01%407.21M | 0.83%322.06M |
| -Notes payable | -42.86%20M | 16.67%35M | -25.00%15M | --25M | --35M | --30M | --20M | ---- | ---- | ---- |
| -Accounts payable | -5.87%320.43M | -10.20%284.81M | -10.11%318.46M | -11.07%316.83M | -16.41%340.4M | -1.52%317.16M | 6.92%354.26M | -1.13%356.26M | 17.01%407.21M | 0.83%322.06M |
| Contract liabilities | -21.65%51.85M | -19.61%50.38M | 16.99%88.27M | 58.45%68.15M | 22.22%66.18M | 7.13%62.67M | 98.90%75.45M | 6.02%43.01M | 12.91%54.15M | -8.47%58.5M |
| Advance receipts | ---- | ---- | ---- | ---- | ---- | ---- | -74.12%1.53M | ---- | ---- | ---- |
| Salaries payable | -3.65%64.3M | -2.58%45.97M | 2.79%98.87M | 19.91%99.39M | -0.14%66.74M | -6.00%47.19M | 1.72%96.18M | 16.55%82.88M | 19.10%66.83M | 11.22%50.21M |
| Taxs payable | -44.86%17.86M | -26.56%32.64M | -29.58%27.1M | 68.61%48.45M | -27.75%32.38M | -5.99%44.45M | -23.97%38.48M | -33.84%28.74M | 13.16%44.82M | 47.19%47.28M |
| Other payable (including interest and dividends) | -28.87%71.93M | -12.17%74.08M | -18.93%71.77M | -21.39%86.24M | 19.93%101.11M | 10.91%84.35M | -0.11%88.53M | 39.11%109.71M | -35.54%84.31M | 15.68%76.05M |
| -Dividend payable | ---- | ---- | ---- | ---- | --16.88M | ---- | ---- | ---- | ---- | ---- |
| -Other payable | -14.61%71.93M | ---- | -18.93%71.77M | ---- | -0.10%84.23M | ---- | -0.11%88.53M | ---- | 19.12%84.31M | ---- |
| Non current liabilities due within one year | -75.73%11.3M | -77.19%17.46M | -75.56%19.52M | -44.88%34.11M | -25.86%46.58M | 12.68%76.55M | 12.52%79.87M | 9.30%61.89M | 10.30%62.83M | 40.65%67.94M |
| Other current liabilities | -22.25%6.67M | -23.00%6.18M | 9.16%10.08M | 61.72%8.84M | 13.40%8.58M | 5.90%8.03M | 116.87%9.24M | 7.99%5.47M | 24.98%7.57M | 4.69%7.58M |
| Total current liabilities | -27.26%594.36M | -29.30%576.55M | -28.76%699.13M | -21.50%807.12M | -23.49%817.06M | -15.91%815.52M | -7.53%981.3M | -5.64%1.03B | -14.90%1.07B | -18.44%969.79M |
| Current liabilities | ||||||||||
| Long term loan | ---- | ---- | ---- | ---- | ---- | -84.37%7.04M | -84.37%7.04M | -84.01%9.04M | -84.01%9.04M | -53.59%45.03M |
| Estimate liabilities | ---- | ---- | -87.53%1.45M | --11.62M | --11.62M | --11.62M | --11.62M | ---- | ---- | ---- |
| Deferred tax liabilities | 43.47%55.51M | 12.79%47.16M | 38.43%48.42M | -33.97%41.41M | -36.83%38.69M | -33.90%41.81M | -42.83%34.98M | 5.21%62.72M | 1.50%61.25M | 3.23%63.26M |
| Long term deferred income | 212.48%12.01M | 367.35%10.67M | 326.48%9.9M | -56.05%3.8M | -56.65%3.84M | -74.82%2.28M | -75.28%2.32M | -44.26%8.66M | -47.35%8.86M | -48.01%9.07M |
| Lease liabilities | -18.90%17.69M | -19.20%19.7M | -12.51%23.6M | 24.24%19.82M | 38.89%21.82M | 8.80%24.38M | 5.19%26.97M | -9.23%15.96M | -10.64%15.71M | -0.10%22.41M |
| Total non current liabilities | 12.16%85.21M | -11.02%77.53M | 0.52%83.36M | -20.45%76.66M | -19.92%75.97M | -37.66%87.13M | -41.29%82.93M | -35.43%96.37M | -37.30%94.86M | -29.47%139.76M |
| Total liabilities | -23.90%679.57M | -27.54%654.08M | -26.47%782.49M | -21.41%883.78M | -23.20%893.03M | -18.65%902.66M | -11.49%1.06B | -9.23%1.12B | -17.31%1.16B | -20.01%1.11B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.25%383.95M | 0.25%383.95M | 0.00%383M | 0.00%383M | 0.00%383M | 0.00%383M | 0.00%383M | 0.00%383M | 0.00%383M | 0.00%383M |
| Capital reserve funds | 0.03%1.12B | -0.10%1.12B | -0.67%1.11B | -0.11%1.12B | 0.00%1.12B | 0.00%1.12B | 0.00%1.12B | 0.00%1.12B | 0.00%1.12B | 0.00%1.12B |
| Surplus reserve funds | 0.00%121.18M | 0.00%121.18M | 0.00%121.18M | 0.00%121.18M | 0.00%121.18M | 0.00%121.18M | 0.00%121.18M | 0.00%121.18M | 0.00%121.18M | 0.00%121.18M |
| Retained profit | 19.95%1.26B | 22.78%1.21B | 23.72%1.13B | 20.12%1.1B | 21.66%1.05B | 19.97%985.22M | 21.57%913.81M | 23.35%918.72M | 22.21%861.83M | 16.03%821.23M |
| Less:Treasury stock | --5.91M | --5.91M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other composite income | -31.75%-32.78M | -18.79%-29.11M | -18.03%-29.14M | -1.85%-24.89M | 7.39%-24.88M | 3.75%-24.51M | 3.54%-24.69M | 6.34%-24.44M | -2.99%-26.86M | 2.32%-25.46M |
| Shareholders equity without minority interests | 7.43%2.84B | 8.28%2.8B | 8.16%2.71B | 7.28%2.7B | 7.68%2.64B | 6.83%2.58B | 6.95%2.51B | 7.50%2.52B | 6.77%2.46B | 4.95%2.42B |
| Minority interests | 40.27%-9.88M | 17.54%-9.29M | -187.88%-8.24M | -535.05%-20.39M | -7,047.65%-16.54M | -682.20%-11.26M | -78.55%9.38M | -110.21%-3.21M | -100.59%-231.47K | -95.23%1.93M |
| Total shareholder equity | 7.73%2.83B | 8.39%2.79B | 7.43%2.71B | 6.61%2.68B | 7.02%2.63B | 6.27%2.57B | 5.38%2.52B | 5.94%2.51B | 4.97%2.46B | 3.22%2.42B |
| Total liabilityies and equity | -0.29%3.51B | -0.95%3.44B | -2.64%3.49B | -2.06%3.56B | -2.69%3.52B | -1.56%3.47B | -0.26%3.58B | 0.74%3.64B | -3.40%3.62B | -5.42%3.53B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- |
| Auditor | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data